Figure.
Prevalence of type-specific HR-HPV DNA among women in the HSS Study, 2003–2005a
aThe prevalence estimates of types of HR-HPV DNA detected on cervical swabs by polymerase chain reaction testing in AI/AN women were compared with non-AI/AN women. Both AI/AN and non-AI/AN women had multiple infections. Thirty-six women in the AI/AN group (i.e., 154 HR-HPV infections identified among 95 women) and 909 in the non-AI/AN group (i.e., 3,732 HR-HPV infections identified among 2,344 women) had multiple infections. All identified HR-HPV infections were included in this figure. No statistical differences in HR-HPV types by AI/AN vs. non-AI/AN women were identified.
HR-HPV = high-risk human papillomavirus
HSS = HPV Sentinel Surveillance
AI/AN = American Indian/Alaska Native
